Compare SELF & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SELF | COCH |
|---|---|---|
| Founded | 1983 | 1995 |
| Country | United States | United States |
| Employees | N/A | 47 |
| Industry | Real Estate Investment Trusts | Blank Checks |
| Sector | Real Estate | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 60.8M | 49.7M |
| IPO Year | 1997 | N/A |
| Metric | SELF | COCH |
|---|---|---|
| Price | $5.13 | $0.64 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $6.00 | $6.00 |
| AVG Volume (30 Days) | 14.6K | ★ 123.1K |
| Earning Date | 05-08-2026 | 05-08-2026 |
| Dividend Yield | ★ 5.25% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.04 | N/A |
| Revenue | ★ $12,705,245.00 | N/A |
| Revenue This Year | $3.04 | $1.58 |
| Revenue Next Year | $3.47 | N/A |
| P/E Ratio | $128.75 | ★ N/A |
| Revenue Growth | ★ 1.40 | N/A |
| 52 Week Low | $4.73 | $0.36 |
| 52 Week High | $5.65 | $1.89 |
| Indicator | SELF | COCH |
|---|---|---|
| Relative Strength Index (RSI) | 49.70 | 41.74 |
| Support Level | $5.02 | $0.64 |
| Resistance Level | $5.21 | $0.73 |
| Average True Range (ATR) | 0.07 | 0.04 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 66.57 | 25.58 |
Global Self Storage Inc is a self-administered and self-managed REIT that owns, operates, manages, acquires, develops, and redevelops self-storage properties. The company's self-storage properties are designed to offer affordable, easily accessible, and secure storage space for residential and commercial customers. It has one segment of Rental operations. Through its wholly-owned subsidiaries, the company owns and/or manages close to thirteen self-storage properties in Connecticut, Illinois, Indiana, New York, Ohio, Pennsylvania, South Carolina, and Oklahoma.
Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.